AVNS - Avanos Medical, Inc.
NYSE
->
Healthcare
->
Medical Devices
Alpharetta,
United States
Type: Equity
AVNS price evolution
AVNS
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $87.7 | $107.1 | $81.8 | $95.7 |
| Short term investments | ||||
| Net receivables | $142.8 | $145.2 | $152.3 | $142.7 |
| Inventory | $163.2 | $156.6 | $148.3 | $200 |
| Total current assets | $487 | $524.6 | $506.9 | $453.8 |
| Long term investments | ||||
| Property, plant & equipment | $144 | $143.9 | $151.7 | $191.8 |
| Goodwill & intangible assets | $1035.6 | $1033.7 | $985.2 | $1066.2 |
| Total noncurrent assets | $1205.4 | $1200.3 | $1159.8 | $1281.1 |
| Total investments | ||||
| Total assets | $1692.4 | $1724.9 | $1666.7 | $1734.9 |
| Current liabilities | ||||
| Accounts payable | $56.3 | $52.1 | $65.4 | $59.6 |
| Deferred revenue | ||||
| Short long term debt | $21.4 | $18.9 | $19.7 | $18.3 |
| Total current liabilities | $234.6 | $170.7 | $160.5 | $158.5 |
| Long term debt | $187.7 | $287.8 | $234.2 | $237.1 |
| Total noncurrent liabilities | $221.5 | $332.1 | $271.4 | $277.7 |
| Total debt | $209.1 | $306.7 | $253.9 | $255.4 |
| Total liabilities | $456.1 | $502.8 | $431.9 | $436.2 |
| Shareholders' equity | ||||
| Retained earnings | -$314.9 | -$325.4 | -$321.7 | -$253.6 |
| Other shareholder equity | -$27 | -$33 | -$28.4 | -$31.3 |
| Total shareholder equity | $1236.3 | $1222.1 | $1234.8 | $1298.7 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $87.7 | $127.7 | $118.5 | $111.5 |
| Short term investments | ||||
| Net receivables | $142.8 | $167.9 | $118.2 | $108.6 |
| Inventory | $163.2 | $190.3 | $150.3 | $168.9 |
| Total current assets | $487 | $499.8 | $418.6 | $467.2 |
| Long term investments | ||||
| Property, plant & equipment | $144 | $194.5 | $206.7 | $223.6 |
| Goodwill & intangible assets | $1035.6 | $1070.4 | $942.8 | $960.2 |
| Total noncurrent assets | $1205.4 | $1287.1 | $1176 | $1205.6 |
| Total investments | ||||
| Total assets | $1692.4 | $1786.9 | $1594.6 | $1672.8 |
| Current liabilities | ||||
| Accounts payable | $56.3 | $67.9 | $56.4 | $67.6 |
| Deferred revenue | ||||
| Short long term debt | $21.4 | $19 | $14.7 | $15.5 |
| Total current liabilities | $234.6 | $185.8 | $139.2 | $166.3 |
| Long term debt | $187.7 | $226.3 | $172.8 | $233.3 |
| Total noncurrent liabilities | $221.5 | $309.9 | $191.5 | $250 |
| Total debt | $209.1 | $280 | $187.5 | $248.8 |
| Total liabilities | $456.1 | $495.7 | $330.7 | $416.3 |
| Shareholders' equity | ||||
| Retained earnings | -$314.9 | -$253.1 | -$310.3 | -$315.5 |
| Other shareholder equity | -$27 | $0.3 | -$33.8 | -$28.1 |
| Total shareholder equity | $1236.3 | $1291.2 | $1263.9 | $1256.5 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $173.3 | $171.3 | $169.4 | $191.7 |
| Cost of revenue | $78.3 | $75.8 | $71.6 | $87.2 |
| Gross Profit | $95 | $95.5 | $97.8 | $104.5 |
| Operating activities | ||||
| Research & development | $6.8 | $6.1 | $6.8 | $7.9 |
| Selling, general & administrative | $74.5 | $78.7 | $93 | $92.7 |
| Total operating expenses | $81.3 | $84.8 | $99.8 | $100.6 |
| Operating income | $13.7 | $10.7 | -$2 | $3.9 |
| Income from continuing operations | ||||
| EBIT | $11.7 | $7.2 | -$65.4 | $3.1 |
| Income tax expense | -$2.1 | $6.2 | -$0.8 | $0.1 |
| Interest expense | $3.3 | $4.7 | $3.5 | $3.5 |
| Net income | ||||
| Net income | $10.5 | -$3.7 | -$68.1 | -$0.5 |
| Income (for common shares) | $10.5 | -$3.7 | -$68.1 | -$0.5 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $673.3 | $820 | $744.6 | $714.8 |
| Cost of revenue | $293.6 | $370 | $380.3 | $341.5 |
| Gross Profit | $379.7 | $450 | $364.3 | $373.3 |
| Operating activities | ||||
| Research & development | $27.2 | $30.6 | $32.3 | $34.9 |
| Selling, general & administrative | $335 | $341.9 | $300.3 | $332.6 |
| Total operating expenses | $362.2 | $372.5 | $332.6 | $367.5 |
| Operating income | $17.5 | $77.5 | $31.7 | $5.8 |
| Income from continuing operations | ||||
| EBIT | -$44.8 | $75.2 | $9.1 | -$44.9 |
| Income tax expense | $2 | $14.7 | $0.6 | -$33.3 |
| Interest expense | $15 | $10 | $3.3 | $15.6 |
| Net income | ||||
| Net income | -$61.8 | $50.5 | $5.2 | -$27.2 |
| Income (for common shares) | -$61.8 | $50.5 | $5.2 | -$27.2 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $10.5 | -$3.7 | -$68.1 | -$0.5 |
| Operating activities | ||||
| Depreciation | $11.5 | $11 | $11.5 | $12.1 |
| Business acquisitions & disposals | $86.9 | -$45 | -$2.5 | |
| Stock-based compensation | $4 | $3.9 | $3.9 | $4 |
| Total cash flows from operations | $12.7 | $29.1 | -$2.6 | -$6.8 |
| Investing activities | ||||
| Capital expenditures | -$5.9 | -$3.9 | -$4 | -$4 |
| Investments | ||||
| Total cash flows from investing | $81 | -$48.9 | -$6.5 | -$4 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$6.4 | -$8.3 | -$2.6 | -$0.5 |
| Net borrowings | -$96.6 | $55 | -$1.5 | -$21.6 |
| Total cash flows from financing | -$114.7 | $46.7 | -$4.1 | -$22.1 |
| Effect of exchange rate | $1.6 | -$1.6 | -$0.7 | $0.9 |
| Change in cash and equivalents | -$19.4 | $25.3 | -$13.9 | -$32 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$61.8 | $50.5 | $5.2 | -$27.2 |
| Operating activities | ||||
| Depreciation | $46.1 | $47.7 | $38.3 | $42.9 |
| Business acquisitions & disposals | $39.4 | -$116.1 | -$4 | |
| Stock-based compensation | $15.8 | $15.9 | $13.2 | $12.1 |
| Total cash flows from operations | $32.4 | $90.9 | $87.3 | -$2.5 |
| Investing activities | ||||
| Capital expenditures | -$17.8 | -$19.3 | -$21 | -$20.2 |
| Investments | ||||
| Total cash flows from investing | $21.6 | -$135.4 | -$21 | -$24.2 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$17.8 | -$43.8 | -$5.3 | $2.5 |
| Net borrowings | -$64.7 | $100.5 | -$50 | -$69.8 |
| Total cash flows from financing | -$94.2 | $56.7 | -$55.3 | -$70 |
| Effect of exchange rate | $0.2 | -$3 | -$4 | $2.9 |
| Change in cash and equivalents | -$40 | $9.2 | $7 | -$93.8 |
News
Fundamentals
| Market cap | $824.21M |
|---|---|
| Enterprise value | $945.61M |
| Shares outstanding | 46.17M |
| Revenue | $705.70M |
|---|---|
| EBITDA | $2.70M |
| EBIT | -$43.40M |
| Net Income | -$61.80M |
| Revenue Q/Q | -20.32% |
| Revenue Y/Y | -13.94% |
| P/E ratio | -13.34 |
|---|---|
| EV/Sales | 1.34 |
| EV/EBITDA | 350.23 |
| EV/EBIT | -21.79 |
| P/S ratio | 1.17 |
| P/B ratio | 0.65 |
| Book/Share | 27.36 |
| Cash/Share | 1.90 |
| EPS | -$1.34 |
|---|---|
| ROA | -3.63% |
| ROE | -4.95% |
| Debt/Equity | 0.37 |
|---|---|
| Net debt/EBITDA | 136.44 |
| Current ratio | 2.08 |
| Quick ratio | 1.38 |